Beam Therapeutics' Series A Round

Beam Therapeutics raised a round of funding on May 14, 2018.

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by scientists specialized in CRISPR gene editing, Beam is pursuing therapies for serious diseases using its pr…

Articles about Beam Therapeutics' Series A Round: